Genprex, Inc. SEC filings GNPX
Genprex, Inc. has 491 filings in SEC EDGAR's recent list, going back to Dec 26, 2013. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 26, 2026 | — |
| S-3 | Shelf registration | Jun 5, 2026 | — |
| S-8 | Employee stock plan registration | Jan 9, 2026 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| S-1/A | Amended registration statement | Nov 26, 2025 | — |
| S-1 | Registration statement | Nov 21, 2025 | — |
| 424B5 | Prospectus supplement | Nov 21, 2025 | — |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| 424B5 | Prospectus supplement | Nov 10, 2025 | — |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 424B3 | Prospectus | Sep 16, 2025 | — |
| S-1 | Registration statement | Sep 12, 2025 | — |
| 424B3 | Prospectus | Jun 17, 2025 | — |
| S-1 | Registration statement | Jun 11, 2025 | — |
| S-1 | Registration statement | May 14, 2025 | — |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| 424B5 | Prospectus supplement | Nov 8, 2024 | — |
| 424B5 | Prospectus supplement | Aug 16, 2024 | — |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| S-8 | Employee stock plan registration | Apr 17, 2024 | — |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| 424B5 | Prospectus supplement | Dec 13, 2023 | — |
| 424B5 | Prospectus supplement | Jul 20, 2023 | — |
| S-3 | Shelf registration | Apr 21, 2023 | — |
| 424B5 | Prospectus supplement | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Feb 17, 2023 | — |
| 424B5 | Prospectus supplement | Nov 18, 2022 | — |
| S-8 | Employee stock plan registration | Aug 16, 2022 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Dec 23, 2020 | — |
| S-3/A | Form s-3/a | Jul 1, 2020 | — |
| S-3 | Shelf registration | Jun 12, 2020 | — |
| 424B3 | Prospectus | May 21, 2020 | — |
| 424B3 | Prospectus | May 21, 2020 | — |
| S-1/A | Amended registration statement | May 15, 2020 | — |
| S-8 | Employee stock plan registration | Apr 2, 2020 | — |
| 424B5 | Prospectus supplement | Feb 19, 2020 | — |
| S-3MEF | Form s-3mef | Feb 19, 2020 | — |
| 424B5 | Prospectus supplement | Jan 24, 2020 | — |
| 424B5 | Prospectus supplement | Jan 17, 2020 | — |
| S-1 | Registration statement | Dec 27, 2019 | — |
| S-1 | Registration statement | Dec 27, 2019 | — |
| 424B5 | Prospectus supplement | Nov 21, 2019 | — |
| S-3/A | Form s-3/a | Oct 4, 2019 | — |
| S-3 | Shelf registration | Sep 16, 2019 | — |
| 424B3 | Prospectus | Jul 27, 2018 | — |
| S-1/A | Amended registration statement | Jul 26, 2018 | — |
| S-1/A | Amended registration statement | Jun 15, 2018 | — |
| S-1 | Registration statement | May 22, 2018 | — |
| 424B3 | Prospectus | Mar 29, 2018 | — |
| POS AM | Post-effective amend. no. 1 to form s-1 | Dec 12, 2017 | — |
| 424B3 | Prospectus | Nov 14, 2017 | — |
| 424B4 | Prospectus | Oct 13, 2017 | — |
| S-1/A | Amended registration statement | Oct 10, 2017 | — |
| S-1/A | Amended registration statement | Sep 26, 2017 | — |
| S-1/A | Amended registration statement | Sep 22, 2017 | — |
| FWP | Free writing prospectus | Sep 15, 2017 | — |
| S-1/A | Amended registration statement | Sep 15, 2017 | — |
| S-1/A | Amended registration statement | Sep 8, 2017 | — |
| S-1/A | Amended registration statement | Aug 18, 2017 | — |
| S-1 | Registration statement | Jul 21, 2017 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNPX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595248
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.